You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

mass. mover

Sales of AMAG injection soar 33 percent

AMAG reported record sales of its Feraheme injection.

Istockphoto

AMAG reported record sales of its Feraheme injection.

Continue reading below

AMAG Pharmaceuticals reported a third-quarter net loss of $145,000, or 1 cent per share, compared with a net loss of $4 million, or 19 cents, a year earlier. The Waltham-based pharmaceutical company also said US sales of its Feraheme injection, which treats iron deficiency anemia in adults, were up 33 percent. During the quarter, AMAG also began promoting MuGard Mucoadhesive Oral Wound Rinse, which it licensed from Access Pharmaceuticals Inc. earlier this year.

Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com